Shorts

1:12
Translating AAIC 2026 Research Into Clinical Care
a month ago
by
Heather Snyder, PhD(+1 more)

0:57
Measuring PIRA More Sensitively in the MS Clinic
a month ago
by
Robert Bermel, MD

1:36
Advancing Women's Sleep Health Across the Lifespan
a month ago
by
Anita Shelgikar, MD, MHPE(+1 more)

0:53
Why Pharmacogenomics Deserves More Attention in Multiple Sclerosis
a month ago
by
Rebecca Cebull, CNP

1:51
RECAP: Neurology News Network - October 10th
a month ago
by
Louie Pasculli

0:42
Why a Single Neurofilament Light Result Falls Short in MS
a month ago
by
Marisa McGinley, DO

1:22
The Compounding Effect of Sleep Apnea on Neurodegeneration
a month ago
by
KuangHua Guo, MD, PhD

0:42
Defining True Precision Medicine in Multiple Sclerosis
a month ago
by
Robert Bermel, MD

1:17
How Sleep Symptoms Could Help Identify Neurodegeneration Before It Starts
a month ago
by
KuangHua Guo, MD, PhD

1:01
RECAP: Neurology News Network - October 3rd
a month ago
by
Louie Pasculli

0:46
Improving Future CIDP Trial Design
a month ago
by
Marco Meglio(+1 more)

1:16
Primary Phase 2 Results for CAR T-Cell Therapy in gMG
a month ago
by
Marco Meglio(+1 more)

1:17
RECAP: Neurology News Network - September 26th
2 months ago
by
Louie Pasculli

0:57
What Other Nerve Conditions Are Teaching Us About Reversing DPN
2 months ago
by
Brian Callaghan, MD, MS

0:57
The 5 to 10 Year Outlook for Diabetic Peripheral Neuropathy
2 months ago
by
Brian Callaghan, MD, MS

0:49
The Research Gaps Standing Between DPN and Reversibility
2 months ago
by
Brian Callaghan, MD, MS

1:51
Advice on Long-Term Strategies for Secondary Stroke Prevention
2 months ago
by
Eva Mistry, MD (+1 more)

1:09
What Should Neurologists Know About Cluster Headache: Part 2
2 months ago
by
Minali Nigam, MD(+1 more)

1:13
What Should Neurologists Know About Cluster Headache: Part 1
2 months ago
by
Jennifer Fokas, MD(+1 more)

1:34
RECAP: Neurology News Network - September 19th
2 months ago
by
Louie Pasculli

0:57
The Future Vision Behind the New Stroke Guidelines
2 months ago
by
Marco Meglio(+1 more)

1:06
What Is the Most Significant Shift in Treating Hypersomnia?
2 months ago
by
KuangHua Guo, MD, PhD(+1 more)

1:44
What Should Clinicians Know About “Brain Fog” From Long COVID?
2 months ago
by
Jacqueline Becker, PhD(+1 more)

1:36
RECAP: Neurology News Network - September 12th
2 months ago
by
Louie Pasculli

1:00
The Broader Lessons From Zilganersen's Path to Approval
2 months ago
by
Amy Waldman, MD

0:52
Why Patients Should Speak Up About Their Concerns Early
2 months ago
by
Mitzi Joi Williams, MD

1:35
The Missing Step Between iPSC Drug Screening and Clinical Trials
2 months ago
by
Ahmet Hoke, MD, PhD

0:35
What iPSC Models Miss About the Nervous System
2 months ago
by
Ahmet Hoke, MD, PhD

1:28
Building a Smarter Drug Development Pipeline for Neuropathy
2 months ago
by
Ahmet Hoke, MD, PhD

0:48
Why Animal Models Still Matter in Neuropathy Research
2 months ago
by
Ahmet Hoke, MD, PhD
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 3 NIMBLE Trial: Cemdisiran Efficacy and Safety Results in gMG
2
Myelin Repair Research in MS: Lessons From Clinical Trials and the Road Ahead
3
From Glucose to Cognition: Where Repurposed Diabetes Drugs Stand in Alzheimer Disease
4
FDA Requires NAION Warning Across GLP-1 Receptor Agonist Class
5
